| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.95 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |